Search

Search Results

• 

  Antibodies to extractable nuclear antigens (ENAS) in systemic lupus erythematosus patients: correlations with clinical manifestations and disease activity

  Y. Emad, T. Gheita, H. Darweesh, P. Klooster, R. Gamal, H. Fathi, N. El-Shaarawy, M. Gamil, M. Hawass, R.M. El-Refai, H. Al-Hanafi, S. Abd-Ellatif, A. Ismail, J. Rasker

  85-91

  06-07-2018

  https://doi.org/10.4081/reumatismo.2018.1027

  2911

  PDF: 1644
• 

  Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center

  F. Dall'Ara, I. Cavazzana, M. Frassi, M. Taraborelli, M. Fredi, F. Franceschini, L. Andreoli, M. Rossi, C. Cattaneo, A. Tincani, P. Airò

  100-105

  06-07-2018

  https://doi.org/10.4081/reumatismo.2018.1023

  2764

  PDF: 1548
• 

  Typing TREX1 gene in patients with systemic lupus erythematosus

  M. Fredi, M. Bianchi, L. Andreoli, G. Greco, I. Olivieri, S. Orcesi, E. Fazzi, C. Cereda, A. Tincani

  1-7

  30-06-2015

  https://doi.org/10.4081/reumatismo.2015.782

  3556

  PDF: 1878
• 

  A method for counting monosodium urate crystals in synovial fluid

  P. Montagna, R. Brizzolara, C. Ferrone, M. Cutolo, S. Paolino, M.A. Cimmino

  29-32

  30-06-2015

  https://doi.org/10.4081/reumatismo.2015.827

  2313

  PDF: 1179
• 

  The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus

  M. Taraborelli, M.G. Lazzaroni, N. Martinazzi, M. Fredi, I. Cavazzana, F. Franceschini, A. Tincani

  137-143

  16-12-2016

  https://doi.org/10.4081/reumatismo.2016.891

  2459

  PDF: 1438
• 

  Preliminary identification of key clinical domains for outcome evaluation in fibromyalgia using the Delphi method: the Italian experience

  F. Salaffi, A. Ciapetti, P. Sarzi Puttini, F. Atzeni, C. Iannuccelli, M. Di Franco, M. Cazzola, L. Bazzichi

  27-34

  19-03-2012

  https://doi.org/10.4081/reumatismo.2012.27

  1162

  PDF: 718
• 

  Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient

  C. Bruni, S. Bellando-Randone, L. Gargani, E. Picano, A. Pingitore, M. Matucci-Cerinic, S. Guiducci

  109-111

  09-09-2016

  https://doi.org/10.4081/reumatismo.2016.889

  2286

  PDF: 1308
• 

  Endothelin receptor antagonists: effects on extracellular matrix synthesis in primary cultures of skin fibroblasts from systemic sclerosis patients

  S. Soldano, P. Montagna, R. Brizzolara, C. Ferrone, A. Parodio, A. Sulli, B. Seriolo, B. Villaggio, M. Cutolo

  326-334

  11-12-2012

  https://doi.org/10.4081/reumatismo.2012.326

  1900

  PDF: 973
• 

  Prospective capillaroscopy-based study on transition from primary to secondary Raynaud’s phenomenon: preliminary results

  E. Bernero, A. Sulli, G. Ferrari, F. Ravera, C. Pizzorni, B. Ruaro, G. Zampogna, E. Alessandri, M. Cutolo

  186-191

  31-10-2013

  https://doi.org/10.4081/reumatismo.2013.186

  4363

  PDF: 1821
• 

  Association between anti-citrullinated alpha enolase antibodies and clinical features in a cohort of patients with rheumatoid arthritis: a pilot study

  A. Alunno, O. Bistoni, F. Pratesi, F. Topini, I. Puxeddu, V. Valentini, G. Cafaro, E. Bartoloni, P. Migliorini, R. Gerli

  67-71

  06-07-2018

  https://doi.org/10.4081/reumatismo.2018.1028

  2739

  PDF: 913
• 

  Long-term cyclic intravenous iloprost in systemic sclerosis: clinical experience from a single center

  S. Casigliani Rabl, A. Della Rossa, P. Pepe, A. D'Ascanio, M. Mosca, A. Di Vita, S. Bombardieri

  158-165

  19-07-2012

  https://doi.org/10.4081/reumatismo.2012.158

  1175

  PDF: 922
• 

  Evidence-based algorithm for diagnosis and assessment in psoriatic arthritis: results by Italian DElphi in psoriatic Arthritis (IDEA)

  G. Lapadula, A. Marchesoni, F. Salaffi, R. Ramonda, C. Salvarani, L. Punzi, L. Costa, F. Caso, D. Simone, G. Baiocchi, C. Scioscia, M. Di Carlo, R. Scarpa, G. Ferraccioli

  126-136

  16-12-2016

  https://doi.org/10.4081/reumatismo.2016.913

  3369

  PDF: 2247
• 

  Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease?

  M. Taraborelli, F. Inverardi, M. Fredi, A. Ceribelli, I. Cavazzana, A. Tincani, F. Franceschini

  321-325

  11-12-2012

  https://doi.org/10.4081/reumatismo.2012.321

  2164

  PDF: 1346
• 

  Neuropeptide levels in Dercum's disease (adiposis dolorosa)

  E. Hansson, J. Manjer, H. Svensson, M. Åberg, B. Fagher, R. Ekman, H. Brorson

  134-141

  19-07-2012

  https://doi.org/10.4081/reumatismo.2012.134

  1274

  PDF: 1710
• 

  Acute colchicine overdose: report of three cases

  A. Aghabiklooei, N. Zamani, H. Hassanian-Moghaddam, S. Nasouhi, M. Mashayekhian

  307-311

  17-03-2014

  https://doi.org/10.4081/reumatismo.2013.720

  4625

  PDF: 1676
• 

  Microvascular damage evaluation in systemic sclerosis: the role of nailfold videocapillaroscopy and laser techniques

  B. Ruaro, A. Sulli, V. Smith, C. Pizzorni, S. Paolino, E. Alessandri, M. Cutolo

  147-155

  21-12-2017

  https://doi.org/10.4081/reumatismo.2017.959

  2726

  PDF: 1285
• 

  Far infrared emitting plaster in knee osteoarthritis: a single blinded, randomised clinical trial

  GL. Bagnato, G. Miceli, M. Atteritano, N. Marino, GF. Bagnato

  388-394

  20-12-2012

  https://doi.org/10.4081/reumatismo.2012.388

  5321

  PDF: 2844
• 

  New approved drugs for psoriatic arthritis

  F.M. Perrotta, E. Lubrano

  57-64

  09-09-2016

  https://doi.org/10.4081/reumatismo.2016.873

  3420

  PDF: 2353
• 

  Coexistence of osteopoikilosis with seronegative spondyloarthritis and Raynaud’s phenomenon: first case report with evaluation of the nailfold capillary bed and literature review

  B. Ruaro, A. Sulli, E. Alessandri, F. Ravera, M. Cutolo

  335-339

  11-12-2012

  https://doi.org/10.4081/reumatismo.2012.335

  1527

  PDF: 1122
• 

  Occurrence of Hashimoto thyroiditis among the first- and second-degree relatives of systemic lupus erythematosus patients with Hashimoto thyroiditis

  L. Carli, C. Tani, S. Vagnani, F. Querci, C. Baldini, R. Talarico, A. Della Rossa, S. Bombardieri, M. Mosca

  203-204

  31-10-2013

  https://doi.org/10.4081/reumatismo.2013.203

  2724

  PDF: 763

  Appendix: 355
• 

  Assessment of treatment effects on digital ulcer and blood perfusion by laser speckle contrast analysis in a patient affected by systemic sclerosis

  B. Ruaro, S. Paolino, C. Pizzorni, M. Cutolo, A. Sulli

  134-136

  21-09-2017

  https://doi.org/10.4081/reumatismo.2017.986

  2756

  PDF: 1147
• 

  Subcutaneous administration of tocilizumab is effective in myointimal hyperplasia remodelling in refractory Takayasu arteritis

  A. Lo Gullo, G. Mandraffino, C.O. Aragona, A. Molica Colella, A. Saitta, E. Imbalzano

  184-188

  21-12-2017

  https://doi.org/10.4081/reumatismo.2017.1013

  1730

  PDF: 952
• 

  Gait analysis in hip viscosupplementation for osteoarthritis: a case report

  L. Di Lorenzo

  199-202

  31-10-2013

  https://doi.org/10.4081/reumatismo.2013.199

  3163

  PDF: 948
• 

  IgA deficiency evidence after anti-TNF-α treatment in a psoriatic arthritis patient: case report

  S. Iervolino, M. Lofrano, M.N.D. Di Minno, F. Foglia, R. Scarpa, R. Peluso

  40-43

  19-03-2012

  https://doi.org/10.4081/reumatismo.2012.40

  1112

  PDF: 1705
• 

  Quality of life measures in systemic lupus erythematosus: a systematic review

  M. Radin, G. El Hasbani, A. Barinotti, D. Roccatello, I. Uthman, A. Taher, S. Sciascia

  07-02-2022

  https://doi.org/10.4081/reumatismo.2021.1447

  8428

  PDF: 2587
• 

  The Italian Society for Rheumatology guidelines on reproductive health in patients with rheumatic diseases

  Chiara Crotti, Nicola Ughi, Emanuela Beretta, Antonio Luca Brucato, Greta Carrara, Maria Sole Chimenti, Paola Conigliaro, Francesca Crisafulli, Giovanna Cuomo, Emma Di Poi, Khadija El Auofy, Micaela Fredi, Maria Chiara Gerardi, Maria Gerosa, Ariela Hoxa, Aurora Ianniello, Maddalena Larosa, Danila Morano, Marta Mosca, Mario Motta, Martina Orlandi, Melissa Padovan, Davide Rozza, Savino Sciascia, Silvia Tonolo, Simona Truglia, Maria Letizia Urban, Anna Zanetti, Sonia Zatti, Angela Tincani

  12-02-2025

  https://doi.org/10.4081/reumatismo.2025.1752

  2873

  PDF: 803

  SUPPLEMENTARY MATERIAL: 270
• 

  The use of tumor necrosis factor inhibitors during high-risk pregnancies in antiphospholipid syndrome: a clinical report of a patient with concomitant Takayasu arteritis and case-based review

  Liala Moschetti, Francesca Crisafulli, Francesca Regola, Rossana Orabona, Sofia Pitsigavdaki, Franco Franceschini, Laura Andreoli, Sonia Zatti, Angela Tincani

  29-07-2025

  https://doi.org/10.4081/reumatismo.2025.1835

  1492

  PDF: 185
• 

  Pain in Sjögren’s syndrome

  C. Giacomelli, R. Talarico, C. Baldini, L. Bazzichi

  39-43

  06-06-2014

  https://doi.org/10.4081/reumatismo.2014.763

  2648

  PDF: 1520
• 

  Seronegative spondyloarthritis and Darier’s disease: more than a casual association?

  C. Cosso, F. Rongioletti, G. Zampogna, D. Camellino, M. Cutolo, M. A. Cimmino

  86-89

  27-05-2013

  https://doi.org/10.4081/reumatismo.2013.86

  3068

  PDF: 682
• 

  Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline

  M. Colaci, D. Giuggioli, M. Sebastiani, A. Manfredi, F. Lumetti, F. Luppi, S. Cerri, C. Ferri

  149-155

  23-05-2016

  https://doi.org/10.4081/reumatismo.2015.837

  2305

  PDF: 1764
• 

  Low levels of vitamin D are common in primary antiphospholipid syndrome with thrombotic disease

  S. Piantoni, L. Andreoli, F. Allegri, P.L. Meroni, A. Tincani

  307-313

  11-12-2012

  https://doi.org/10.4081/reumatismo.2012.307

  2786

  PDF: 1306
• 

  Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients

  M. Ferrito, G. Cincinelli, M. Manara, R. Di Taranto, E.G. Favalli, R. Caporali

  17-07-2023

  https://doi.org/10.4081/reumatismo.2023.1544

  1413

  PDF: 767

• PO:14:195 | Real-world effectiveness of anifrolumab in achieving treatment targets and reducing systemic lupus erythematosus disease burden: 6-month interim analysis of the REVEAL study Chiara Cardelli^1|2, Chiara Tani¹, Luca Moroni³, Filippo Vesentini⁴, Francesca Bottazzi⁵, Micaela Fredi⁶, Ettore Silvagni⁷, Matteo Piga⁸, Flavia Riccio⁹, Fulvia Ceccarelli¹⁰, Ginevra De Marchi¹¹, Edoardo Biancalana¹², Gianluca Moroncini¹³, Rita Mulè¹⁴, Mariele Gatto¹⁵, Laura Coladonato¹⁶, Paola Conigliaro¹⁷, Maria Gerosa¹⁸, Andrea Picchianti Diamanti¹⁹, Benedetta Bianchi²⁰, Federica Maiolini²⁰, Michela Gasparotto²⁰, Serena Guiducci²⁰, Maria Ilenia De Andres²⁰, Alberto Lo Gullo²⁰, Silvia Noviello²⁰, On Behalf Of The Reveal Investigators²⁰, Marta Mosca¹. | ¹Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa; ²Department of Medical Biotechnologies, University of Siena, Siena; ³Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milano; ⁴Rheumatology Unit, Department of Medicine, University of Padua, Padova; ⁵Department of Internal Medicine and Therapeutics, University of Pavia, Pavia; ⁶Rheumatology and Clinical Immunology, Department of Clinical and Experimental Sciences, University of Brescia, Brescia; ⁷Section of Rheumatology, Department of Medical Sciences, University of Ferrara; AOU Sant'Anna, Ferrara; ⁸Rheumatology Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari;  ⁹Department of Precision Medicine, University of Campania Luigi Vanvitelli, Napoli; ¹⁰Rheumatology Unit, Dept. of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Roma; ¹¹Division of Rheumatology, Department of Medicine, Azienda Sanitaria Universitaria del Friuli Centrale, Udine; ¹²Internal Interdisciplinary Medicine Unit, Department of Experimental and Clinical Medicine, University of Florence, Firenze; ¹³Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona; ¹⁴Azienda Ospedaliero-Universitaria di Bologna, Internal Medicine and Rheumatology, IRCCS S. Orsola Malpighi, Bologna; ¹⁵Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin; AO Mauriziano, Torino; ¹⁶Rheumatology Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, Bari; ¹⁷Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, Tor Vergata University of Rome, Roma; ¹⁸Clinical Rheumatology, ASST Gaetano Pini CTO; Department of Clinical Sciences and Community Health, University of Milano, Milano; ¹⁹Department of Clinical and Molecular Medicine, Sapienza University of Rome; AOU Sant'Andrea, Roma, Italy; ²⁰Italian REVEAL Study Group Italy, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2031

  164
• 

  Anxiety and depression in rheumatologic diseases: the relevance of diagnosis and management

  R. Torta, F. Pennazio, V. Ieraci

  92-97

  06-06-2014

  https://doi.org/10.4081/reumatismo.2014.769

  3214

  PDF: 1998
• 

  Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies

  C. Gioia, A. Picchianti Diamanti, R. Perricone, M.S. Chimenti, A. Afeltra, L. Navarini, A. Migliore, U. Massafra, V. Bruzzese, P. Scolieri, C. Meschini, M. Paroli, R. Caccavale, P. Scapato, R. Scrivo, F. Conti, B. Laganà, M. Di Franco

  19-12-2023

  https://doi.org/10.4081/reumatismo.2023.1602

  2153

  PDF: 540

• Pregnancy in patients affected by axial-spondyloarthritis: a narrative review of disease activity and obstetric outcomes

  M. Filippini, G. Fontana, P. Bizioli, F. Crisafulli, R. Orabona, S. Zatti, F. Franceschini, A. Tincani

  11-09-2024

  https://doi.org/10.4081/reumatismo.2024.1697

  1720

  PDF: 713
• 

  Evolution in the use of musculoskeletal ultrasonography in a Rheumatology Unit over 14 years

  S. Gil Barato, E. de Miguel Mendieta, E. Martin-Mola

  8-12

  30-06-2015

  https://doi.org/10.4081/reumatismo.2015.792

  1676

  PDF: 1023
• 

  Identification of subgroups among fibromyalgia patients

  B. Auvinet, D. Chaleil

  250-260

  28-09-2012

  https://doi.org/10.4081/reumatismo.2012.250

  2005

  PDF: 1668
• 

  Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series

  E. Chessa, M. Piga, A. Floris, A. Mathieu, A. Cauli

  175-183

  21-12-2017

  https://doi.org/10.4081/reumatismo.2017.1007

  3940

  PDF: 1939
• 

  Slipped capital femoral epiphysis in adults: case report and review of literature

  C.C. Macía-Villa, I. Sanchez-Lite, J. Medina-Luezas

  40-47

  23-06-2016

  https://doi.org/10.4081/reumatismo.2016.860

  3532

  PDF: 1708
• 

  IgG4-related disease: findings from a retrospective cohort in Colombia

  Diana N. Rincón-Riaño, Daniel E. Rodríguez-Ariza, Cristhyan Pacheco, Laura J. Garcia-Ballesteros, Luisa Fernanda Galindo, Fabio A. Torres

  03-11-2025

  https://doi.org/10.4081/reumatismo.2025.1887

  822

  PDF: 47
• 

  First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome

  B. Palterer, G. Vitiello, D. Cammelli

  75-77

  03-08-2017

  https://doi.org/10.4081/reumatismo.2017.923

  2005

  PDF: 964
• 

  PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors

  Cristina Garufi, Silvia Mancuso, Fulvia Ceccarelli, Letizia Caruso, Cristiano Alessandri, Manuela Di Franco, Roberta Priori, Valeria Riccieri, Rossana Scrivo, Simona Truglia, Fabrizio Conti, Francesca Romana Spinelli

  05-11-2024

  https://doi.org/10.4081/reumatismo.2024.1725

  2671

  PDF: 404
• 

  Bone mineral density in women on long-term mud-bath therapy in a Salus per Aquam (SPA) environment

  A. Loi, S. Lisci, A. Denotti, A. Cauli

  121-125

  24-07-2013

  https://doi.org/10.4081/reumatismo.2013.121

  3116

  PDF: 1116
• 

  The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis

  N. Ughi, R. Padoan, C. Crotti, S. Sciascia, G. Carrara, A. Zanetti, D. Rozza, S. Monti, D. Camellino, F. Muratore, G. Emmi, L. Quartuccio, S. Morbelli, K. El Aoufy, S. Tonolo, R. Caporali, S. De Vita, C. Salvarani, M.A. Cimmino

  07-02-2022

  https://doi.org/10.4081/reumatismo.2021.1470

  10022

  PDF: 2283
• 

  Classification and clinical assessment

  A. Marchesoni, F. Cantini

  79-87

  05-06-2012

  https://doi.org/10.4081/reumatismo.2012.79

  1353

  PDF: 2077
• 

  Nailfold capillaroscopy in the rheumatological current clinical practice in Italy: results of a national survey

  F. Ingegnoli, M. Cornalba, R. De Angelis, S. Guiducci, D. Giuggioli, C. Pizzorni, V. Riccieri, M. Sebastiani, A. Sulli, M. Cutolo

  29-12-2022

  https://doi.org/10.4081/reumatismo.2022.1508

  1324

  PDF: 567

  Appendix: 1271
• 

  Translation and cross-cultural adaptation into Italian of the self-administered FLARE-RA questionnaire for rheumatoid arthritis

  N. Ughi, T. Schioppo, I. Scotti, V. Merlino, A. Murgo, O. De Lucia, B. Fautrel, F. Guillemin, R. Christensen, F. Ingegnoli

  21-30

  10-04-2020

  https://doi.org/10.4081/reumatismo.2020.1230

  1447

  PDF: 919

• PO:38:283 | Accuracy of chatgpt 4 omni in providing clinical recommendations in musculoskeletal care: a valuable support for clinicians and patients? Dario Taborelli¹, Silvia Negro¹, Federico Padovani², Tiziano Innocenti^1|3, Stefano Salvioli¹ | ¹DINOGMI, Università di Genova, Savona; ²Dipartimento di Neuroscienze e Riabilitazione, Università di Ferrara; ³GIMBE Foundation, Bologna, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2226

  140
• 

  Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy

  M. Tasso, N. Bertolini, E. Mostacciuolo, S. Passavanti, J.M.E. Luppino, A. Del Puente, R. Peluso, F. Santelli, R. Scarpa, L. Costa, F. Caso

  29-12-2022

  https://doi.org/10.4081/reumatismo.2022.1511

  2178

  PDF: 1009